Download this datacard
Overview
Lobbying Costs
9,999€
Financial year: Jan 2017 - Dec 2017
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
H. Lundbeck A/S (HLU)
EU Transparency Register
118500617129-29 First registered on 27 Apr 2015
Goals / Remit
H. Lundbeck A/S is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are Alzheimer's disease, depression, Parkinson's disease and schizophrenia.
Our approximately 5,000 employees in 55 countries are engaged in the entire value chain throughout research, development, manufacturing, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have production facilities in Denmark, France and Italy. Lundbeck generated revenue of DKK 17.2 billion in 2017 (EUR 2.3 billion; USD 2.6 billion).
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck.Main EU files targeted
initiatives relevant for the pharmaceutical industry
Address
Head Office
Ottiliavej 9
Valby 2500
DENMARK -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Anders Schroll (Vice President, Corporate Communication & Global Public Affairs)
Person with legal responsibility
Mr Anders Götzsche (Interim CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Efpia - European Federation of Pharmaceutical Industries and Associations
http://www.efpia.eu/
DI - Confederation of Danish Industry
http://di.dk/English/Pages/English.aspx
EBC- European Brain Council
http://www.europeanbraincouncil.org/Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2017 - Dec 2017
Lobbying costs for closed financial year
9,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
None
Other activities
Legislation and public policy areas relevant for the pharmaceutical industry and Lundbeck's focus within psychiatric and neurological disorders, eg. mental health
- Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 12 Sep 2022 Location Copenhagen Subject Green and digital transition and Pharma strategy. Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Margrethe Vestager (Executive Vice-President)
- Christina Holm Eiberg (Cabinet member)
-
Date 21 May 2021 Location Copenhagen Subject Industrial Strategy Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Margrethe Vestager (Executive Vice-President)
Other Lobbyists
- Meetings